Understanding how social factors affect anticoagulation in atrial fibrillation patients
Mentoring in patient-oriented research in social determinants and atrial fibrillation
This study looks at how things like where you live and your personal situation affect how well people with atrial fibrillation can get and stick to their blood-thinning medication, with the hope of finding better ways to help everyone stay on track and prevent strokes.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10894656 on NIH RePORTER |
What this research studies
This research investigates how social determinants of health influence the accessibility and adherence to oral anticoagulation therapy in patients with atrial fibrillation (AF). It aims to explore both individual and neighborhood-level social factors that may impact patients' ability to receive and maintain their anticoagulation treatment. By leveraging data from clinical trials and electronic health records, the study seeks to identify disparities in treatment adherence and develop mentoring programs to address these issues. The ultimate goal is to improve stroke prevention strategies for individuals affected by AF.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with atrial fibrillation who may face challenges in accessing or adhering to anticoagulation therapy due to social factors.
Not a fit: Patients who do not have atrial fibrillation or those who are already effectively managing their anticoagulation therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved access to anticoagulation therapy and better health outcomes for patients with atrial fibrillation.
How similar studies have performed: Previous research has shown that addressing social determinants of health can significantly improve treatment adherence and health outcomes in various patient populations, suggesting a promising avenue for this study.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Magnani, Jared W. — University of Pittsburgh at Pittsburgh
- Study coordinator: Magnani, Jared W.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.